Struthers Richard Scott 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Dec 4, 2024
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2024-12-02$57.57/sh−10,000$575,700→ 100,000 total(indirect: By Trust)
Holdings
- 257,485
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
- 570,805(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $57.57 per share. The range of sales prices on the transaction date was $56.90 to $58.07 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.